She s the face of NC s fight against COVID-19. Meet Dr. Mandy Cohen, Tar Heel of the Year
Dec. 23
The News & Observer recognizes North Carolina residents who have made significant contributions in the last year and beyond. These people have made a difference in our region, state and elsewhere. Here are our stories.
Once, many years ago, a promising third-year medical resident did not know how to treat one of her patients. They were both young women, the patient and the resident, when their lives intersected at Massachusetts General Hospital in Boston.
For weeks, the patient had been losing weight and also her hair, troubling symptoms for someone in her early 20s. The resident, training to become a doctor of internal medicine, ordered test after test that revealed no answers. One day a technician approached the resident with the patient s vitals, and some advice: Maybe you should ask the patient if she d been eating regularly.
COLUMN: Science shows retaliation like a drug woodwardnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from woodwardnews.net Daily Mail and Mail on Sunday newspapers.
With results available in less than a minute and the cards costing 50 cents a pop, scientists say this smell app could outperform traditional tests at a fraction of the price.
E-Mail
Skokie, IL - The ISSCR is bringing together successful biotech CEOs who have transformed scientific breakthroughs into thriving businesses that are improving human health into one program 7-8 January 2021.
VISION2030 comes at a pivotal moment in regenerative medicine and stem cell science as discovery, translation, and investment intersect.
Thursday, 7 January
STEMCELL Technologies Executive Interview
Interviewed by ISSCR Board Member Valentina Greco, Yale University School of Medicine, USA
STEMCELL Technologies mission is to advance the pursuit of scientific knowledge by supplying high quality, innovative reagents, tools, and services that enable life science research.
Surrozen Executive Interview
Claudia Janda, Princes Máxima Centrum, Netherlands l Surrozen Founder
Published: Dec 17, 2020
LEXINGTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that it appointed Mary Ann Gray, Ph.D., to its Board of Directors. We are delighted to welcome Dr. Gray to Keros’ Board of Directors,” said President and Chief Executive Officer Jasbir Seehra, Ph.D. Her deep experience guiding both growing and commercial-stage companies as a board member, coupled with her scientific and financial acumen, will be a tremendous asset as we continue to further advance multiple assets in the clinic.